Skip to main content
. 2021 Sep 24;12:759267. doi: 10.3389/fphar.2021.759267

FIGURE 1.

FIGURE 1

LINC01001 is highly expressed and associated with poor overall survival of NSCLC patients. (A) Evaluating the IC50 of crizotinib in NSCLC cells. *p < 0.05, **p < 0.01, ***p < 0.001 vs A549/H1299 group. (B) LINC01001 is highly expressed in crizotinib-resistant NSCLC cells. ***p < 0.001 vs WT group. Error bars represent SD. Data represent three independent experiments.